Piramal Pharma informs about disclosure

12 Sep 2023 Evaluate

In accordance with the provisions of Regulation 30 of the SEBI Listing Regulations, Piramal Pharma has informed that pursuant to an intimation received from Legal Affairs Bureau, Tokyo (the ‘Authority’) on September 12, 2023, voluntary liquidation of Piramal Pharma Japan GK, a step-down wholly - owned subsidiary of the Company has been approved by the Authority. The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are given under Annexure A.

The above information is a part of company’s filings submitted to BSE.

Piramal Pharma Share Price

222.40 5.45 (2.51%)
08-Apr-2025 09:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1688.75
Dr. Reddys Lab 1108.55
Cipla 1433.45
Lupin 1982.65
Zydus Lifesciences 859.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...